Article
Breast cancer prevention in high-risk women.
Best practice & research. Clinical obstetrics & gynaecology - 1 May 2020
Thorat Mangesh A, Balasubramanian Rajeshkumar
Abstract excerpt
Women at high risk of developing breast cancer are a heterogeneous group of women including those with and without high-risk germline mutation/s. Prevention in these women requires a personalised and multidisciplinary approach. Preventive therapy with selective oestrogen receptor modulators (SERMs) like tamoxifen and aromatase inhibitors (AIs) substantially reduces breast cancer risk well beyond the active...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
